D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 62 Citations 12,138 279 World Ranking 1582 National Ranking 69

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Enzyme

Philip M. Hansbro mainly investigates Immunology, Immune system, Inflammation, Asthma and COPD. Philip M. Hansbro has researched Immunology in several fields, including Respiratory infection, Disease and Lung. The Immune system study combines topics in areas such as Respiratory disease and Respiratory tract infections.

His Inflammation study incorporates themes from Angiogenesis, Interleukin, Interleukin 13, Cytokine and Signal transduction. The study incorporates disciplines such as PI3K/AKT/mTOR pathway, Antagomir, Allergy and Glucocorticoid in addition to Asthma. His research in COPD tackles topics such as Pathology which are related to areas like Periostin, Cell and Idiopathic pulmonary fibrosis.

His most cited work include:

  • The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation (423 citations)
  • Immunological decision-making: how does the immune system decide to mount a helper T-cell response? (382 citations)
  • Emerging pathogenic links between microbiota and the gut-lung axis (381 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Immunology, Inflammation, COPD, Asthma and Immune system. His work carried out in the field of Immunology brings together such families of science as Respiratory infection, Respiratory system, Lung and Disease. His Disease research incorporates themes from Microbiome and Intensive care medicine.

His research in Inflammation intersects with topics in Tumor necrosis factor alpha, Receptor and Cytokine. As part of one scientific family, Philip M. Hansbro deals mainly with the area of COPD, narrowing it down to issues related to the Bioinformatics, and often microRNA. His Immune system study frequently intersects with other fields, such as Chlamydia.

He most often published in these fields:

  • Immunology (58.53%)
  • Inflammation (28.44%)
  • COPD (26.61%)

What were the highlights of his more recent work (between 2019-2021)?

  • Immunology (58.53%)
  • COPD (26.61%)
  • Inflammation (28.44%)

In recent papers he was focusing on the following fields of study:

His main research concerns Immunology, COPD, Inflammation, Asthma and Lung. His study in Immunology is interdisciplinary in nature, drawing from both Microbiome, Disease and Respiratory system. His biological study spans a wide range of topics, including Interleukin 33 and Lung cancer.

Philip M. Hansbro combines subjects such as Unfolded protein response, Cytokine, Lung injury and Airway resistance with his study of Inflammation. His Asthma study combines topics in areas such as Allergy, Bronchoalveolar lavage and FEV1/FVC ratio. He has included themes like Fibrosis and Innate lymphoid cell in his Lung study.

Between 2019 and 2021, his most popular works were:

  • Animal and translational models of SARS-CoV-2 infection and COVID-19. (43 citations)
  • Animal and translational models of SARS-CoV-2 infection and COVID-19. (43 citations)
  • SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. (32 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Enzyme

Philip M. Hansbro focuses on Immunology, COPD, Inflammation, Respiratory system and Pathogenesis. His Immunology study integrates concerns from other disciplines, such as Proteases and Cohort. His COPD research is multidisciplinary, incorporating perspectives in Lung cancer, Antibiotics, Disease and Hypoxia.

His studies deal with areas such as Pseudomonas aeruginosa, Lung injury, Streptococcus pneumoniae and Cytokine as well as Inflammation. His Respiratory system research incorporates elements of Bioinformatics, Drug delivery, Fibroblast growth factor, Hedgehog and Bone morphogenetic protein. His Pathogenesis study deals with Pulmonary fibrosis intersecting with Drug discovery and Berberine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Gerard E. Kaiko;Jay C. Horvat;Kenneth W. Beagley;Philip M. Hansbro.
Immunology (2008)

589 Citations

The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation

Bernardo S Franklin;Lukas Bossaller;Lukas Bossaller;Dominic De Nardo;Jacqueline M Ratter.
Nature Immunology (2014)

550 Citations

Emerging pathogenic links between microbiota and the gut-lung axis

Kurtis F. Budden;Shaan L. Gellatly;David L. A. Wood;Matthew A. Cooper.
Nature Reviews Microbiology (2017)

485 Citations

Methods for the isolation and identification of Listeria spp. and Listeria monocytogenes: a review

Uta Gasanov;Denise Hughes;Philip Michael Hansbro.
Fems Microbiology Reviews (2005)

433 Citations

Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals

Kate L. Ormerod;David L. A. Wood;Nancy Lachner;Shaan L. Gellatly.
Microbiome (2016)

317 Citations

Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.

Meenu Mehta;Deeksha;Devesh Tewari;Gaurav Gupta.
Chemico-Biological Interactions (2019)

286 Citations

The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

Kamal Dua;Kamal Dua;Kamal Dua;Ridhima Wadhwa;Gautam Singhvi;Vamshikrishna Rapalli.
Drug Development Research (2019)

260 Citations

Airway epithelial regulation of pulmonary immune homeostasis and inflammation.

Teal S. Hallstrand;Tillie L. Hackett;William A. Altemeier;Gustavo Matute-Bello.
Clinical Immunology (2014)

219 Citations

Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Simon Keely;Nicholas J. Talley;Philip M. Hansbro.
Mucosal Immunology (2012)

212 Citations

Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection

Linda J. Berry;Danica K. Hickey;Kathryn A. Skelding;Shisan Bao.
Infection and Immunity (2004)

197 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philip M. Hansbro

Peter G. Gibson

Peter G. Gibson

University of Newcastle Australia

Publications: 48

Brian G. Oliver

Brian G. Oliver

Woolcock Institute of Medical Research

Publications: 44

Eicke Latz

Eicke Latz

University of Bonn

Publications: 43

Kenneth W. Beagley

Kenneth W. Beagley

Queensland University of Technology

Publications: 38

Paul S. Foster

Paul S. Foster

University of Newcastle Australia

Publications: 35

Eileen A. McLaughlin

Eileen A. McLaughlin

University of Auckland

Publications: 27

Peter A. B. Wark

Peter A. B. Wark

University of Newcastle Australia

Publications: 27

Jodie L. Simpson

Jodie L. Simpson

University of Newcastle Australia

Publications: 27

Peter Timms

Peter Timms

University of the Sunshine Coast

Publications: 27

Kian Fan Chung

Kian Fan Chung

National Institutes of Health

Publications: 25

Sebastian L. Johnston

Sebastian L. Johnston

National Institutes of Health

Publications: 23

Darryl A. Knight

Darryl A. Knight

University of Newcastle Australia

Publications: 22

Samuel K. Sheppard

Samuel K. Sheppard

University of Bath

Publications: 19

Paul J. Hertzog

Paul J. Hertzog

Hudson Institute of Medical Research

Publications: 17

Bart N. Lambrecht

Bart N. Lambrecht

Ghent University

Publications: 17

Ian M. Adcock

Ian M. Adcock

National Institutes of Health

Publications: 17

Something went wrong. Please try again later.